Abstract

IN-VITRO ANTIDIABETIC ACTIVITY OF SIDDHA POLYHERBAL DRUG MARUTHAMPATTAI KUDINEER

B. Vinubharathi*, N. J. Muthukumar, V. Mahalakshmi and V. Banumathi

Abstract

Diabetes mellitus is characterized by hyperglycaemia and disturbances of carbohydrate, protein and fat metabolisms, secondary to an absolute or relative lack of the hormone insulin. The number of people in the world with diabetes has increased dramatically over recent years. It is also predicted that by 2030, India, china and the United States will have the largest number of people with diabetes. Siddha is an indigenous medical system of india. It encompasses a broad range of therapies for efficiently managing Madhumegam, a clinical entity that correlates with diabetes mellitus. A wide range of siddha medicines has long been used with success for treating this disease and one such medicine is Maruthampattai kudineer. The present study was carried out to investigate the inhibitory effect of Maruthampattai kudineer, on alpha –amylase, which serves as major a digestive enzyme.

Keywords: Siddha, Diabetes mellitus, Maruthampattai kudineer, Alpha Amylase inhibitory activity.